1-4 of 4
Yu-Hsiu T. Lin
Close
Sort by
Journal Articles

Functional Multi-Omics Reveals Genetic and Pharmacologic Regulation of Surface CD38 in Multiple Myeloma

Priya Choudhry, Olivia Gugliemini, Huimin Geng, Vishesh Sarin, Letitia Sarah, Yu-Hsiu T. Lin, Neha Paranjape, Poornima Ramkumar, Makeba Marcoulis, Donghui Wang, Paul Phojanakong, Veronica Steri, Byron Hann, Martin Kampmann, Arun P Wiita
Journal: Blood
Blood (2021) 138 (Supplement 1): 2648.
https://doi.org/10.1182/blood-2021-147007
Published: 2021
Journal Articles

Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and -Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology

Ian Ferguson, BA, Yu-Hsiu T. Lin, BA, Sami Tuomivaara, PhD, Jeffrey L. Wolf, MD, Thomas G. Martin, III, MD, Sandy W. Wong, MD, Nina D. Shah, MD, Christoph Driessen, MD, Brian G. Van Ness, PhD, Arun P. Wiita, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1803.
https://doi.org/10.1182/blood-2019-131681
Published: 2019
Journal Articles

In Vitro -Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell Malignancies

Matthew Nix, PhD, Yu-Hsiu T. Lin, BA, Huimin Geng, PhD, Makeba Marcoulis, BA, Paul Phojanakong, BA, Donghui Wang, BA, Veronica Steri, PhD, Jeffrey Whitman, MD, Sagar Bapat, MD PhD, Elliot Stieglitz, MD, Anne Deucher, MD PhD, Kristie L White, MD MD, Byron C Hann, MD PhD, Arun P. Wiita, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1337.
https://doi.org/10.1182/blood-2019-130938
Published: 2019
Journal Articles

Integrating Phosphoproteomics and Transcriptional Classifiers Reveals "Hidden Signaling" in Multiple Myeloma Including Differential KRAS and NRAS Mutant Effects

Yu-Hsiu T. Lin, BA, Gergory P. Way, PhD, Margarette C. Mariano, MS, Makeba Marcoulis, BA, Ian Ferguson, BA, Casey S. Greene, PhD, Arun P Wiita, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 469.
https://doi.org/10.1182/blood-2018-99-113683
Published: 2018